Search research articles
Contact Us
Filters
Showing results (561-570 of 619) with videos related to
Page
of 62
Sort By:
Leukemia
|
May 16, 2015
Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment
K Sevcikova, Z Zhuang, G Garcia-Manero, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises
Wen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
Wen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
Physical Review Letters
|
October 15, 2008
Anomalous photogalvanic effect of circularly polarized light incident on the two-dimensional electron gas in Al{x}Ga{1-x}N/GaN heterostructures at room temperature
X W He, B Shen, Y H Chen, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes
Anmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Research
|
February 19, 2013
CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer
Lei Du, Guanhua Rao, Hongyi Wang, et al.
The Journal of Clinical Investigation
|
June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60
Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cell Discovery
|
November 22, 2016
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
Collene R Jeter, Bigang Liu, Yue Lu, et al.
BMC Genomics
|
July 13, 2019
Systematic evaluation of RNA-Seq preparation protocol performance
Hsueh-Ping Chao, Yueping Chen, Yoko Takata, et al.
Page
of 62
Search research articles
Search
Showing results (561-570 of 619) with videos related to
Sort By:
Page
of 62
Leukemia
|
May 16, 2015
Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment
K Sevcikova, Z Zhuang, G Garcia-Manero, et al.
Biorxiv : the Preprint Server for Biology
|
December 4, 2023
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises
Wen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
International Journal of Molecular Sciences
|
February 24, 2024
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
Wen Jess Li, Yunfei Wang, Xiaozhuo Liu, et al.
Physical Review Letters
|
October 15, 2008
Anomalous photogalvanic effect of circularly polarized light incident on the two-dimensional electron gas in Al{x}Ga{1-x}N/GaN heterostructures at room temperature
X W He, B Shen, Y H Chen, et al.
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Cell-resolved high-dimensional imaging analysis, therapeutic modeling, and a Phase Ib clinical study establish BCL-2 as a target across heterogeneous CRPC subtypes
Anmbreen Jamroze, Xiaozhuo Liu, Surui Hou, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 2, 2025
Phase Ib Study of Enzalutamide with Venetoclax in Patients with Metastatic Castration-Resistant Prostate Cancer
Stuthi Perimbeti, Anmbreen Jamroze, Dharmesh Gopalakrishnan, et al.
Cancer Research
|
February 19, 2013
CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer
Lei Du, Guanhua Rao, Hongyi Wang, et al.
The Journal of Clinical Investigation
|
June 2, 2022
A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60
Rahul Kumar, Ajay K Chaudhary, Jordan Woytash, et al.
Cell Discovery
|
November 22, 2016
NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
Collene R Jeter, Bigang Liu, Yue Lu, et al.
BMC Genomics
|
July 13, 2019
Systematic evaluation of RNA-Seq preparation protocol performance
Hsueh-Ping Chao, Yueping Chen, Yoko Takata, et al.
Page
of 62